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Evidence for localised HIV related micro–
epidemics associated with the decentralised 
provision of antiretroviral treatment in rural 
South Africa: a spatio–temporal analysis of 
changing mortality patterns (2007–2010)
Background: In this study we analysed the spatial and temporal 
changes in patterns of mortality over a period when antiretroviral 
therapy (ART) was rolled out in a rural region of north–eastern South 
Africa. Previous studies have identified localised concentrated HIV 
related sub–epidemics and recommended that micro–level analyses 
be carried out in order to direct focused interventions.
Methods Data from an ongoing health and socio–demographic sur-
veillance study was used in the analysis. The follow–up was divided 
into two periods, 2007–2008 and 2009–2010, representing the times 
immediately before and after the effects on mortality of the decen-
tralised ART provision from a newly established local health centre 
would be expected to be evident. The study population at the start 
of the analysis was approximately 73 000 individuals. Data were ag-
gregated by village and also using a 2 × 2 km grid. We identified vil-
lages, grid squares and regions in the site where mortality rates with-
in each time period or rate ratios between the periods differed 
significantly from the overall trends. We used clustering techniques 
to identify cause–specific mortality hotspots.
Findings: Comparing the two periods, there was a 30% decrease in 
age and gender standardised adult HIV–related and TB (HIV/TB) 
mortality with no change in mortality due to other causes. There was 
considerable spatial heterogeneity in the mortality patterns. Areas 
separated by 2 to 4 km with very different epidemic trajectories were 
identified. There was evidence that the impact of ART in reducing 
HIV/TB mortality was greatest in communities with higher mortality 
rates in the earlier period.
Conclusions: This study shows the value of conducting high resolu-
tion spatial analyses in order to understand how local micro–epidem-
ics contribute to changes seen over a wider area. Such analyses can 
support targeted interventions.
South Africa is one of the countries worst affected by the HIV pandemic. 
In 2011 there were estimated to be 5.6 million people infected with HIV, 
with an HIV prevalence of 17.6% for those aged between 15 and 49 [1]. 
Electronic supplementary material:  
The online version of this article contains supplementary material.
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alanga province in South Africa. [18] The site runs alongside 
the Kruger National Park and is close to the border with Mo-
zambique (Figure 1). Approximately one third of the popu-
lation are of Mozambican ethnic origin, mainly refugees from 
the Mozambican civil war. A number of the pre–existing vil-
lages gave over land in which ‘Mozambican’ settlements were 
established. These were initially characterised as having 
poorer levels of infrastructure and greater poverty than the 
established villages [19]. These former refugee communities 
are mainly located in the eastern part of the study site.
The area is predominantly rural though close to a number 
of peri–urban settlements. It is characterised as having high 
unemployment, a high level of poverty and relatively poor 
levels of educational attainment [18]. This has resulted in 
a high level of out–migration for economic reasons. Often 
the migrants retain strong connections with their original 
households and financial remittances from migrants are an 
importance source of income [20].
The baseline census for the AHDSS was carried out in 
1992, and the present annual cycle of household follow–
up visits was established in 1999. In 2007 the study site 
population was approximately 73 000 individuals. In order 
to maintain anonymity alphabetical identifiers rather than 
names are used to identify the villages in this study.
Population distribution
The study site is made up of discretely bounded villages 
(Figure 2). Central areas of the villages often have a maxi-
mum population density greater than 1000 people/km2 
which is more typical of an urban area in this region. The 
northern portion of the study site generally has a lower 
population density than the western and central parts.
ART and VCT provision in the Agincourt site
Effective ART became available worldwide in the mid 
1990s. In South Africa, however, the treatment only be-
In recent years the outlook for those infected has improved 
considerably with the percentage of those requiring anti-
retroviral treatment (ART) who are receiving the drugs in-
creasing from 30% in 2009 [2] to 75.2% in 2011 [3]. The 
impact of ART programmes in reducing HIV related mor-
tality and increasing life expectancy has been reported in a 
number of studies in sub–Saharan Africa [4–7]. However, 
the analysis of trends at a national, regional or district lev-
el may mask important local variations. It is important to 
understand this micro–level variation in order to effective-
ly target interventions [8–12] as behaviours linked to high-
er or lower risk may be clustered in local communities 
[13,14].The data required for such detailed analyses are 
often only available in sites where the dynamics of a popu-
lation can be followed in detail over time. Hence, Health 
and Demographic Surveillance Sites (HDSSs) provide the 
ideal platform for such analyses. [15,16]. Wand and Ram-
jee [10,11,14] identified local high prevalence spatial clus-
ters of HIV and sexually transmitted infections amongst 
women in the Greater Durban area of Kwa Zulu Natal in 
South Africa. Tanser and colleagues [12] reviewed data 
from studies in various sub–Saharan African countries to 
provide evidence for the likely benefit of targeted interven-
tions aimed at high risk groups to supplement more gen-
eral population level approaches to HIV prevention.
Here we describe changing spatial patterns in the local de-
velopment of an HIV epidemic over a period of time during 
which a health centre was established in order to test and 
treat those infected with HIV in addition to providing gen-
eral health care for the local community. The goal of this 
analysis was to gain an understanding of which communi-
ties and sub–communities have benefitted preferentially 
from the enhanced access to treatment and those for which 
the situation may have deteriorated. By use of a grid overlay 
we were able break down communities into smaller sub–
units and calculate cause–specific mortality trends in each 
of the grid squares. We also used clustering techniques to 
obtain complementary information on areas and periods of 
time where mortality risks differed from those expected. 
Clustering methods have been used previously to investi-
gate HIV related mortality patterns in a rural South African 
setting, indicating the value of the technique in identifying 
locations for targeted interventions [8,17]. Using these mul-
tiple methodologies we were able to gain a fine grained un-
derstanding of the localised epidemic dynamics.
METHODS
Location of the study
This study was carried out in the Agincourt Health and So-
cio–Demographic Survey site (AHDSS) located in the Bush-
buckridge sub–district of Ehlanzeni municipality of Mpum-
Figure 1. The location of the Agincourt HDSS in the South 
Africa and the surrounding region.
June 2014  •  Vol. 4 No. 1 •  010403	 2	 www.jogh.org •  doi: 10.7189/jogh.04.010403
V
IE
W
PO
IN
TS
PA
PE
RS
Localised HIV microepidemics in decentralized provision of antiretroviral treatment in rural South Africa
came available in the public sector in 2004 [2]. Subse-
quently there were delays in rolling out ART across the 
country particularly in rural areas such as that in which the 
Agincourt HDSS is located.
In 2002 a programme was introduced to provide voluntary 
counselling and HIV testing (VCT) services in the 5 health 
centres operating in the study area [21]. Prior to this VCT 
had only been available outside the site. Two of the second-
ary level hospitals serving the population in the study site 
began to provide ART treatment between 2004 and 2005. 
To improve clinic access a programme of decentralisation 
of ART services began in 2008 when a clinic in the study 
site (Agincourt) and another in a peri–urban settlement 
(Thulamahashe) just to the west of the site started to pro-
vide ART. At the same time a community health centre, 
Bhubezi, initially operating outside the public sector and 
providing general health care with an emphasis on HIV 
testing and treatment was established. Throughout this pe-
riod ART was available from private providers.
This study examines changes in mortality in two consecu-
tive time periods 2007–2008 and 2009–2010 the periods 
immediately before and after the possible effects on mor-
tality of the decentralised ART provision from the Bhubezi 
health centre would be expected to be evident.
Data used in the study
The core information captured in the annual AHDSS 
rounds were updates of the residency status and vital in-
formation for all household members. This was collected 
by interviewing the most knowledgeable available repre-
sentative. For all deaths reported, a detailed verbal autopsy 
(VA) interview was carried out. The latitude and longitude 
of every dwelling was captured. Residents of two villages 
which were added to the site in 2009 were excluded from 
the analysis. The study population was restricted to males 
and females aged 15 years and above.
Cause of death (CoD) was assigned using the InterVA–4 
model [22,23]. The InterVA–4 input variables are based on 
the questions in the standardised World Health Organisa-
tion (WHO) VA instrument released in 2012 [24]. A com-
puter implementation of the InterVA–4 probabilistic mod-
el is freely available for download from http://www.interva.
net. InterVA–4 uses a Bayesian probabilistic technique to 
calculate the likelihood of a particular cause of death for an 
individual based upon the presence or absence of particu-
lar signs or symptoms. An important advantage of the In-
terVA model over clinicians’ assessments is the consistency 
in cause of death ascertainment over time. A multicentre 
validation study of the InterVA–4 model against known 
HIV serostatus has shown good validity [25].
The variables required for the InterVA–4 input were de-
rived from the responses given to the Agincourt VA ques-
tionnaire. In addition to directly matching variables, key 
words or phrases from narrative fields which were specifi-
cally associated with InterVA–4 input variables were iden-
tified. To overcome misspelling in the narratives, a string 
similarity matching algorithm (Jaro–Winkler) [26] was ap-
plied to identify similar strings, a cut–off score of 0.9 was 
used to define a match. These matches were checked man-
ually. The matching algorithms were programmed using 
routines implemented in T–SQL, the proprietary imple-
mentation of the SQL standard in the SQL*ServerTM 2008 
software package. [Microsoft Corporation, Redmond, 
Washington USA].
Figures from 2009 [27] indicate that around 70% of those 
infected with tuberculosis are co–infected with HIV in 
South Africa. Due to this high level of co–morbidity deaths 
due to HIV–related disease (WHO VA code –01.03 HIV/
AIDS related death) and pulmonary tuberculosis (WHO 
VA code –01.09) were joined in a single category, HIV/TB. 
All other deaths for which a CoD was available were cate-
gorised as non–HIV/TB.
Analytical approach
Mortality rates were directly standardised by age and gen-
der in each 2-year period using the age/gender proportions 
of the entire site in the relevant period as the standard. The 
adult population was subdivided into 3 categories for the 
standardisation; 15 to 49, 50 to 65 and over 65. The stan-
dardised rates and the associated 90% confidence intervals 
(CI) were calculated using Stata, version 10.0 SE (Stata 
Corp., College Station, Texas, USA). Chi–Squared values 
and Student T–tests were used to compare the effect of in-
determinate cause of death data.
An initial comparison of mortality patterns aggregated the 
individuals into their villages of residence. This approach 
was based on that of previous studies [28,29] where mor-
tality clusters were identified using village centroids. A ra-
tionale for this approach is that within the study site each 
village is geographically isolated from the others with its 
Figure 2. Mean population densities within the study site, 
2007–2010.
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own leadership which to some extent can influence local 
characteristics. However there is also likely to be intra–vil-
lage heterogeneity which such an analysis may not iden-
tify. A study of national HIV prevalence data in South Af-
rica [9] emphasised the danger in aggregating data only by 
province as this led to a loss of understanding of localised 
prevalence levels for communities which crossed provincial 
boundaries. A similar problem exists with village–level ag-
gregation. For this reason, a grid was created extending 
across the site. After investigating various grid sizes a 2 × 2 
km grid was chosen in order to give reasonable numbers 
of deaths and strata–specific populations in each square. A 
previous study of mortality patterns in the Butajira HDSS 
site in Ethiopia used a similar approach in order to get a 
more fine grained understanding of spatio–temporal mor-
tality patterns [30].
The person years at risk were calculated for each individ-
ual in each of the two year time periods using the start of 
the period to begin the residence episode and either an end 
event, out–migration, death or the end of the period to 
right–censor the person time accrued. Mortality rate ratios 
were calculated for each grid square or village. In the grid 
analysis, if the lower bound of the 90% CI of the rate or 
rate ratio was higher than the mean value for the site that 
was classified as a significantly high value. Similarly if the 
upper bound was less than the mean this was classified as 
a grid square with a significantly low value. The grid and 
population density maps were developed using the ArcGIS 
software (ESRI 2011. ArcGIS Desktop: Release 10. Red-
lands, CA: Environmental Systems Research Institute). 
Other studies have suggested that lengthy travel times to 
clinics can provide a significant barrier to access [31–33], 
conversely better road links may also lead to greater op-
portunities for social mixing and hence a higher risk of ex-
posure to infection [8]. Hence we assessed the proximity 
of areas of high or low mortality rates or rate ratios to the 
clinics and roads.
Spatio–temporal cluster analysis was carried out using Kull-
dorff’s spatio–temporal scan statistic as implemented in the 
SaTScanTM software v9.1 to identify the location and evalu-
ate the statistical significance of spatial and temporal clus-
ters of mortality [34]. In this analysis a cylindrical scanning 
window is moved across the study area, so that each loca-
tion of the window captures a unique set of individuals dur-
ing a specific range of dates. The radius of each cylinder is 
allowed to vary. The height of the cylinder corresponds to 
a specific range of dates. To evaluate statistical significance, 
a comparison is made between the number of cases (eg, 
cause specific deaths) within the scanning window and the 
number of cases outside of that window using a maximum 
likelihood ratio test statistic. The centre of the scanning win-
dow moves in geographical space and time allowing signif-
icant high or low clusters of deaths in space and/or time to 
be identified. The population at each dwelling was derived 
from the total number of person years rounded to the near-
est integer value with a minimum value of 1. The dates of 
death were aggregated by month. The maximum spatial and 
temporal windows used were 50% of the population at risk 
and 50% of the entire period (2 years) respectively. A Pois-
son probability model with a maximum of 999 Monte–Car-
lo replications was used in the analysis. A cut–off P value of 
0.2 was used to identify clusters of interest. 
In order to obtain an objective measure of the degree of 
spatial homogeneity in the pattern of rate ratios, a calcula-
tion was made of the Global Moran’s I statistic using the 
GeoDa software [35]. A distance weight matrix was created 
using rook contiguity to indicate the nearest neighbours 
associated with a particular grid square. A Global Moran’s 
I statistic of close to zero indicates a random spatial distri-
bution, values approaching +1 or –1 indicate that there is 
overall a high degree of spatial correlation.
FINDINGS
Between 2007 and 2010, 3660 deaths were recorded in the 
study site. Of these, 567 (15.5%) were excluded from the 
analysis as a cause of death could not be assigned due to 
either the initial verbal autopsy not having been carried out 
or there being a lack of symptomatic data. For the remain-
ing deaths, 2584 occurred in those aged 15 years and over. 
A further 13 deaths were excluded from the grid analysis 
as no geographical coordinates for the place residence of 
these individuals were available.
To assess the possible effects of indeterminate causes of 
death, an analysis was carried out of the spatial distribution 
of deaths with and without a CoD assignment for the en-
tire study population. The spatial separation of the cen-
troids of the home residences for the two categories was 
464 m indicating that there was no significant spatial bias 
introduced. The percentage of indeterminate CoD assign-
ments was greater in 2009 to 2010 than in 2007 to 2008 
(16.3% compared with 15.7%, P = 0.014). There were 
more indeterminate CoDs for males than females (17.2% 
compared with 14.2%, P = 0.012). Also those with indeter-
minate CoDs were on average younger than those for 
whom a cause of death was assigned (36.7 years compared 
to 42.5 years, P < 0.001)
Village level analysis of mortality
HIV/TB mortality. There was a large range of values for 
the standardised mortality rates (SMRs) for HIV/TB during 
both time periods (see Table S1 in the Online Supplemen-
tary Document). The rate ratio between the latter and ear-
lier period was 0.70 (90% CI = 0.64–0.77) indicating a de-
crease in the HIV/TB mortality rates of between 23% and 
36% with a point estimate of 30%. The rate ratios (RR) for 
individual villages are shown in Figure 3.
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A rate ratio greater than 1 indicating an increase in the adult 
HIV/TB mortality rates was seen for two of the twenty–five 
villages (Q and K.) For twenty–two villages a decrease in 
the HIV/TB mortality rates were seen. However, for four-
teen of these the upper bound of the 90% CI was greater 
than or equal to 1 indicating that the evidence for a de-
crease was weak. For one village the HIV/TB mortality rate 
remained unchanged.
Village Q had the highest rate ratio value of 1.35 (90% 
CI = 0.78–2.34) indicating a point estimate of a 35% in-
crease in the HIV/TB mortality rate, as the lower bound of 
the confidence interval is less than 1 it is possible that there 
was a trend towards a decrease in the rate over the period. 
The lowest HIV/TB mortality rate ratios were 0.37 (90% 
CI = 0.15–0.91) for village Y, 0.38 (90% CI = 0.26–0.56) for 
village H and 0.43 (90% CI = 0.23–0.80) for village L, in 
each case the upper bound of the confidence interval is less 
than 1 indicating a rate decrease to 
be a reasonable interpretation. Vil-
lages H and L are geographically 
close neighbours to village Q.
The gradient of the trend line fitted 
to the plotted points (Figure 3) was 
0.091, indicating a decrease of close 
to 9% in the mortality rate ratio be-
tween the two periods for each unit 
increase in the mortality rate in the 
earlier period. The low R2 value of 
0.318 showed that there was a sig-
nificant amount of variation around 
this overall trend.
Non–HIV/TB mortality. Similar 
to HIV/TB deaths, there were large 
variations between villages in the 
SMRs for deaths due to causes oth-
er than HIV/TB during both time periods (see Table S2 in 
the Online Supplementary Document). The standardised 
adult rate ratio for non–HIV/TB mortality between 2007 
to 2008 and 2009 to 2010 was 1.01 (90% CI = 0.92–1.10) 
indicating that there was no overall change evident in the 
non HIV/TB mortality rates for adults between the two 
periods. The range in rate ratios was from 0.42 (90% 
CI = 0.25–0.71) for village N to 1.84 (90% CI = 1.19–
2.86) for village W. With the upper bound of the rate ra-
tio for village N less than 1 and the lower bound for vil-
lage W greater than 1 it is reasonable to interpret this as 
evidence for significantly different changes in cause–spe-
cific rates between the two.
The graph in Figure 4 shows a decrease in the rate ratio as 
the initial mortality rate increases with a gradient of 0.110 
for the trend line. The R2 value of 0.361 again indicates sig-
nificant variation around the overall trend.
Figure 3. A comparison of the HIV/TB 
mortality rate ratios (with 90% confidence 
intervals) and mortality rates for 2007–2008 
(points are labelled with the village codes). 
The best fit trend line is superimposed on the 
points with the associated R–squared value.
Figure 4. A comparison of the Non HIV/TB mortality rate ratios (with 90% confidence 
intervals) and mortality rates for 2007–2008 (points are labelled with the village codes). 
The best fit trend line is superimposed on the points with the associated R–squared value.
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Gridded mortality plots
HIV/TB mortality. Figure 5 shows the HIV/TB mortality 
rates in each grid square for 2007 to 2008 and 2009 to 
2010. In 2007 to 2008 (Figure 5, upper panel), only two 
grid squares with significantly high rates were seen one at 
the extreme east of the site (10.41 deaths/1000 person-
years, PY), the other towards the west (563.23 deaths/1000 
PY). The latter was in a square with a very low population 
and thus likely to be a statistical outlier. 
Grid squares with significantly low 
standardised adult HIV/TB mortality 
rates were predominantly in the south-
ern and western areas of the site with 
two additional squares located to the 
north of the Bhubezi health commu-
nity health centre (Bhubezi).
In 2009 to 2010 (Figure 5, lower pan-
el) there were 4 grid squares with sig-
nificantly low rates in the eastern re-
gion of the site in the area around 
Bhubezi. Other low rate grid squares 
were identified towards the west and 
north of the site. There were two grid 
squares with significantly high HIV/TB 
mortality rates one containing Bhubezi 
(8.23 deaths/1000 PY) and the other 
towards the southwest of the site 
(15.76 deaths/1000 PY)
The rate ratio plot (Figure 6) shows 
four grid squares with significantly 
high rate ratios indicating an increase 
in the adult HIV/TB mortality rates be-
tween the two periods. One was locat-
ed in the square containing Bhubezi 
(rate ratio = 1.39) and another directly 
to the north (rate ratio = 1.46), another 
was in the extreme south of the site 
(rate ratio = 2.67) and one towards the 
west (rate ratio = 3.22). Of the four grid 
squares with significantly low rate ra-
tios, two were located to the east of 
Bhubezi. The rate ratios for these two 
squares are 0.20 and 0.33, indicating 
decreases of 80% and 67% respectively in the adult HIV/
TB mortality rates in these regions. Other grid squares with 
low mortality rate ratios were seen in the north and west 
of the site.
The Moran’s I value for the HIV/TB mortality rate ratios was 
–0.03 indicating the spatial distribution of changes in HIV/
TB mortality rates was essentially random with no evidence 
for global spatial correlation.
Non–HIV/TB mortality. For adult deaths other than those 
caused by HIV related disease or TB, in the period 2007 to 
2008, two grid squares with significantly high mortality 
rates were identified towards the north of the site and one 
in the south (see Figure S1 in Online Supplementary Docu-
ment). In contrast, low rate grid squares were mainly found 
in the eastern, western and central areas of the site. In 2009 
to 2010 the four grid squares showing significantly high 
rates were located in the eastern, southern and central re-
Figure 5. HIV/TB mortality rates (deaths per 1000 person-year, 
PY) from 2007 to 2008 (upper panel) and 2009–2010 (lower 
panel) in 2 km grid squares for the Agincourt HDSS site. For 
grid squares with significantly low rates, the upper bound of 
the 90% confidence interval is less than the mean rate. For grid 
squares with significantly high rates the lower bound of the 
90% confidence interval is greater than the mean rate. The label 
is the mortality rate for the grid square.
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gions of the site. There were eight grid squares with signif-
icantly low rates. These were distributed throughout the site 
other than in the extreme southern and western areas.
Two grid squares had significantly high rate ratio values, one 
just below Bhubezi (rate ratio = 2.23) and one towards the 
centre of the site (rate ratio = 1.92). Five grid squares showed 
significantly low rate ratios, one was just to the north-east 
of Bhubezi the others towards the centre of the site.
The Moran’s I value for the non–HIV/TB rate ratios was 
–0.02 indicating the spatial variation in non–HIV/TB mor-
tality rate changes was essentially random again showing 
no evidence for global spatial correlation.
Spatio–temporal clustering
For HIV/TB mortality two low risk clusters (1 & 2) and 1 
high risk cluster (3) were identified as shown in Figure 7. 
Cluster 1 (P = 0.04) was located in the centre of the site the 
time period was from August to December of 2010. Clus-
ter 2 (P = 0.03) to the southeast of Cluster 1 was between 
November 2007 and September 2008. Cluster 3 had a low-
er level of statistical significance (P = 0.12), its time period 
from June 2007 to May 2008 partially overlapped that for 
cluster 2. It was located in the lower southeast region of 
the site.
For the deaths due to causes other than 
HIV/TB, two low risk clusters were iden-
tified (4 & 5) over the same time period, 
October 2010 to December 2010. Clus-
ter 4 (P = 0.05) covers a large area of the 
west and central region of the site, whilst 
cluster 5 with a low level of statistical 
significance (P = 0.18) covers a slightly 
smaller area towards the east of the site.
DISCUSSION
In this study three complementary tech-
niques were used to investigate the 
changes in the geographical patterns of 
cause specific adult mortality over a pe-
riod in which ART was rolled out and a 
community health centre opened in a 
rural South African community.
There was a 30% decrease in adult HIV/
TB mortality between 2007 to 2008 and 2009 to 2010. 
However, for one community, village Q, there was a 35% 
increase in the adult HIV/TB mortality rate over the same 
period. As the rates were age and gender standardised, oth-
er factors must explain these differences. Village Q was 
originally established to provide homes for Mozambican 
refugees, this suggested that the ethnic profile of the village 
might be an important factor in determining the take–up 
of ART and subsequent decrease in mortality. However in 
our study we also found that in other predominantly Mo-
zambican communities, such as villages L, R, S and T, there 
were decreases in the HIV/TB mortality rate over the same 
period. Hence ethnicity alone cannot explain the mortality 
changes. Furthermore, village L neighbours village Q, high-
lighting the geographical heterogeneity in the epidemic tra-
jectories seen for closely neighbouring communities. This 
heterogeneity in rates between villages is consistent with 
patterns in all cause mortality identified between 1992 and 
2007 [36] in this area.
The inverse relationship between the adult mortality rate 
ratio and the baseline adult HIV/TB mortality rate suggests 
that at a population level the impact of ART was greatest in 
the communities where the need was greatest. It is possible 
the higher HIV/TB mortality rates in some communities 
increased the awareness of the disease and hence the like-
lihood of individuals in those areas getting tested and start-
ing treatment. Further qualitative studies would be needed 
to confirm whether this was the case.
There was no evidence of overall changes in adult mortal-
ity rates due to causes other than HIV related disease and 
pulmonary TB between the two time periods. This suggests 
that the reduction in HIV/TB mortality was explained by 
the provision of ART, rather than a general improvement 
Figure 6. HIV/TB mortality rate ratios for 2009–2010 compared 
to 2007–2008 for the Agincourt HDSS site. For grid squares 
with significantly low rate ratios, the upper bound of the 90% 
confidence interval is less than the mean rate ratio. For grid 
squares with significantly high ratios, the lower bound of the 
90% confidence interval is greater than the mean rate ratio. The 
label is the mortality rate ratio for the grid square.
www.jogh.org •  doi: 10.7189/jogh.04.010403	 7	 June 2014  •  Vol. 4 No. 1 •  010403
V
IE
W
PO
IN
TS
PA
PE
RS
Mee P et al.
in other aspects of health care provision in the area. How-
ever we do see highly heterogeneous patterns of change 
between different communities. Also the patterns of change 
in mortality rates differ markedly for the two categories of 
cause of death. An example of this is seen for village O 
which had a 37% increase in non–HIV/TB mortality and a 
34% decrease in HIV/TB mortality, between
The analysis by grid square further emphasises the pattern 
of local heterogeneity and shows how this can also be seen 
at a sub–village level. As an example, the four populated 
grid squares located towards the extreme west of the site 
in the map of adult HIV/TB mortality (Figure 6) are sub-
sections of the same village. Three have increased HIV/TB 
mortality rates whilst the fourth shows a reduction of 71% 
between the earlier and later time periods. It is possible that 
the characteristics of the different sub–regions of the village 
are influenced by those of neighbouring communities.
The existence of clusters of high and low HIV/TB mortal-
ity towards the east of the study site (Figure 7) also shows 
the local heterogeneity in the risk of death related to these 
conditions. In comparison, a study looking at infant HIV/
TB deaths in the site between 2000 and 2005 identified 
high mortality risk hot spots in the central, south–eastern 
and south–western areas [37]. This analysis shows differ-
ent geographical locations for the high and low risk clusters 
of mortality attributable to different causes consistent with 
a previous study of adult mortality patterns in the site from 
1993–2010 [38].
Visual analysis showed no evidence for lower HIV/TB rate 
ratios in areas close to the clinics providing ART. A study in 
a rural area of KwaZulu–Natal in South 
Africa showed that ART uptake was in-
versely related to the distance individ-
uals lived from the clinic providing 
treatment [39]. Previous studies in this 
site did identify associations between 
the mortality risk and the straight-line 
distance between an individual’s resi-
dence and local clinics [40,41].
These patterns have important impli-
cations for those planning new health 
facilities or initiating community–
based health interventions. Whilst it is 
important that the physical barriers to 
access are reduced, for example by lo-
cating new health centres in order to 
obtain the greatest reduction in travel 
times for the population which is 
served [31], consideration should also be made to the differ-
ent morbidity patterns across the community. Furthermore 
as we see from the patterns of HIV/TB rate ratios in Figure 
6 different areas within a short distance of the Bhubezi health 
centre saw very different epidemic trajectories over the pe-
riod of the study. This suggests that to have an effective im-
pact, the various barriers to access experienced by different 
sub–sections of the community, must be addressed [42]. 
Clearly there are issues of temporality in such an approach 
as we are making assumptions about levels of current illness 
based on past mortality levels. Also knowing the place of 
residence of an individual at the time of their death does not 
necessarily tell you where the person was exposed to the risk 
factors leading to death. This is especially important in an 
area like this where we see significant numbers of individu-
als returning from urban areas when their illness has pro-
gressed such that they are no longer able to maintain em-
ployment and live independently [43].
A potential limitation in this analysis is the rather high level 
of indeterminate causes of death. However there is no evi-
dence that the indeterminate data introduced a spatial bias. 
The preponderance of indeterminate causes among younger 
individuals and males probably reflects patterns of tempo-
rary migration, with a number of those deaths occurring 
away from home and hence difficult to follow–up by verbal 
autopsy. As there was a slightly higher proportion of deaths 
for which no cause could be defined in 2009–2010 com-
pared to 2007–2008 (16.3% vs 15.7%) we can assume that 
the cause specific mortality ratios are a slight underestimate. 
Also as relatively short time windows were used to accumu-
late the data, the numbers of deaths accrued was relatively 
low compared to previous studies [36] leading to relatively 
wide confidence intervals for the rates and rate ratios calcu-
lated.
Figure 7. Spatio–temporal clusters with significantly raised or 
lowered rates of deaths due to HIV/TB and Non HIV/TB over 
the period 1 Jan 2007 to 31 Dec 2010.
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CONCLUSIONS
The patterns that emerge from this study are complex. In 
some areas there appears to be a high level of intra–village 
coherence with individual villages showing distinct mor-
tality characteristics which differ from those of neighbour-
ing villages. In others the pattern is less clear. This work 
confirms the conclusions made by other studies in the re-
gion that identified heterogeneous pattern of micro–epi-
demics within a more generalised epidemic [10–12,14,17]. 
Our results confirm trends shown by Tanser and colleagues 
[8] of considerable local geographic variation in HIV prev-
alence in a rural area of Kwa Zulu Natal South Africa. How-
ever spatial patterns of HIV related mortality will be affect-
ed by both the distributions of risk factors for infection and 
local availability of testing and treatment. In our case there 
are no obvious associations with the location of major roads 
crossing the site. This study shows that a micro–level anal-
ysis may be useful in mounting an appropriate public 
health response to HIV in a local area. In a further study, 
currently being prepared for publication, we assess the in-
fluence of various risk factors which may explain the spa-
tial patterns that have been identified. Conclusions drawn 
from a spatial analysis such as is presented here can be used 
as a starting point for investigations of factors influencing 
the differing current morbidity patterns seen in different 
communities.
Geo–located cause specific mortality data as used in this 
analysis is often lacking in resource poor regions [44]. 
However a mobile phone based application which can be 
used to collect verbal autopsy data and assign causes of 
death, as well as automatically registering GPS coordinates, 
is now available [45]. This gives the potential in the future 
for a greater geographic coverage of mortality data beyond 
the existing limited number of research sites for which it is 
available.
UNAIDS and others have emphasised that in deciding how 
to respond to HIV one must “Know your epidemic” [46]. 
This study emphasises the importance of that approach.
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